PCV59 Cost-Effectiveness of Dabigatran Etexilate Versus Apirin Plus Clopidogrel Combination in Stroke Prevention in Atrial Fibrillation (SPAF)- Russian Payer Perspective
Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.662
https://www.valueinhealthjournal.com/article/S1098-3015(12)00727-9/fulltext
Title :
PCV59 Cost-Effectiveness of Dabigatran Etexilate Versus Apirin Plus Clopidogrel Combination in Stroke Prevention in Atrial Fibrillation (SPAF)- Russian Payer Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)00727-9&doi=10.1016/j.jval.2012.03.662
First page :
A122
Section Title :
Cardiovascular Disorders
Open access? :
No
Section Order :
137